Cannabis Insights

February 4, 2018

Oregon Product Sales Trends

Oregon’s cannabis sales trends reflect a significant relative decline in demand for flower and pre-rolls, whereas concentrates/extracts have seen strong growth. From December 2016 to December […]
February 4, 2018

Uh-Oregon: A Cautionary Reminder About Rushing Out West

By J.J. McCoy, Senior Managing Editor for New Frontier Data As the cannabis industry makes its first, long-anticipated forays into completely open Pacific Coast legalized markets, […]
January 28, 2018

Increase in U.S. Cannabis Consumption Rate

Since 2011, more than 7.5 million adults have joined the ranks of now 22.4 million regular cannabis users. New Frontier Data’s research suggests that the increase […]
January 28, 2018

Know the Risks: Valuations in the Cannabis Marketplace

By Andrew Lines, MAI, Principal Valuations within the growing cannabis industry don’t always seem to be consistent with operator or investor expectations; this can be due […]
January 27, 2018

Turning Over a New Cannabis Leaf in New York?

By J.J. McCoy, Senior Managing Editor for New Frontier Data It has been some time coming for New York’s state of mind to open up to […]
January 21, 2018

2 Million Medical Patients Impacted?

The Rohrabacher-Blumenauer Amendment works to protect medical cannabis programs in 29 states and the District of Columbia. The states most affected by a non-renewal of this […]
January 21, 2018

Rohrabacher-Blumenauer: What Are The Stakes – Revisited

By J.J. McCoy, Senior Managing Editor for New Frontier Data In what has become a de facto annual event on Capitol Hill (where a version was […]
January 14, 2018

WHO to DOJ, re: CBD: It’s All (Medicinally) Good

By J.J. McCoy, Senior Managing Editor for New Frontier Data Newly published findings from the World Health Organization (WHO) about the medicinal benefits of cannabidiol (CBD) […]
January 14, 2018

Cannabis Market Recovers after Steep Decline

Attorney General Jeff Sessions’ Jan. 4 announcement rescinding the Cole Memo sparked a steep but short-lived selloff of U.S. cannabis stocks. By January 11th, stocks had […]